RatLesNetv2

RatLesNetv2: Fully Convolutional Neural Network for Rodent Brain Lesion Segmentation

RatLesNetv2 performs automated segmentation of rodent brain lesions in magnetic resonance (MR) imaging using a fully convolutional neural network with an autoencoder-like architecture and residual blocks, implemented in Python and PyTorch. It supports end-to-end training directly on 3D T2-weighted MR images without preprocessing.


Key Features:

  • Fully Convolutional Architecture: Autoencoder-like ConvNet with residual blocks to improve optimization and segmentation accuracy.
  • 3D End-to-End Training: Processes 3D T2-weighted rat brain MRI volumes without preprocessing.
  • Quantitative Performance: Achieves higher Dice coefficients, lower Hausdorff distance, and more compact segmentations with fewer holes compared to other ConvNets.
  • Large-Scale Evaluation: Validated on 916 T2-weighted rat brain MRI scans from 671 rats across nine lesion stages in focal cerebral ischemia studies.

Scientific Applications:

  • Focal Cerebral Ischemia Research: Enables automated lesion segmentation in rodent brain MR images to support neurological studies and drug development.
  • Reproducible Quantification: Exceeds inter-rater agreement in manual segmentation, improving precision and reproducibility.

Methodology:

RatLesNetv2 employs a fully convolutional neural network with residual blocks in an autoencoder-like configuration, trained end-to-end on 3D T2-weighted rat brain MRI volumes. Performance was assessed using Dice coefficient and Hausdorff distance metrics on a dataset of 916 scans spanning nine lesion stages.

Topics

Details

License:
MIT
Tool Type:
command-line tool, library, workflow
Programming Languages:
Python
Added:
3/19/2021
Last Updated:
3/31/2021

Operations

Publications

Valverde JM, Shatillo A, De Feo R, Gröhn O, Sierra A, Tohka J. RatLesNetv2: A Fully Convolutional Network for Rodent Brain Lesion Segmentation. Frontiers in Neuroscience. 2020;14. doi:10.3389/fnins.2020.610239. PMID:33414703. PMCID:PMC7783408.

PMID: 33414703
PMCID: PMC7783408
Funding: - H2020 Marie Sklodowska-Curie Actions: 691110, 740264 - Academy of Finland: 275453, 316258